Press Releases

Filters (1)
January 19, 2004

ELOXATIN™ submitted in the United States and in Europe for the adjuvant treatment of patients with colon cancer

Read more
January 12, 2004

Eloxatin™ (oxaliplatin for injection) approved in the United States for the 1st line treatment of metastatic colorectal cancer

Read more
January 7, 2004

ELOXATIN® is becoming a cornerstone therapy for the treatment of metastatic colorectal cancer in Europe

Read more
August 27, 2002

Debiopharm extends its collaboration with Sanofi-Synthélabo on Eloxatin®

Read more
August 19, 2002

Media Alert: successful registration after shortest ever review by the FDA of Eloxatin

Read more